A study presented at ACR Convergence 2025 suggests that GLP 1 receptor agonists reduce flares and systemic inflammation in Rheumatoid Arthritis (RA) patients.
New Study Finds Diabetes, Weight Loss Drugs May Lower Rheumatoid Arthritis Flares
NDTV Latest10/2938
Raw Story
The Babylon Bee
Massillon Independent
WCPO 9
The Atlanta Journal-Constitution Sports
Nicki Swift
The Daily Bonnet